Novostia

Health & Medical Electronics · Cardiovascular Devices

Overview

Menu principal. Caution: Novostia technology is an investigational device not yet approved for sale.

Funding and backers

Total raised
$6.6M
2 rounds on record
Latest round
$6.6M
Angel · Sep 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$2.7M
1 grant · CORDIS
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 19, 2024 Raised a round Angel $6.6M Apr 1, 2020 Won a grant $2.7M · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Angel Sep 2024 $6.6M — news.qq.com
Grant Apr 2020 $2.7M — CORDIS
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
(no title)Venture round $30.7M · 10 mo ago · Founded 2024 · 51-200 employees
Submit Connect Investigational Use Only. Products under development by Ventaris are investigational medical devices and are not approved or…
OrthoPulse® is the first and only approved medical device that uses near infrared light technology to shorten treatment time and reduce…
Bayou SurgicalVenture round $5M · 12 mo ago · 11-50 employees
Bayou Surgical troCarWash System Medical Device.
AI agents for medical device development.
Medical Device Developmentto Enhance the Quality of Life. 再生医療機器開発.
Caretaker MedicalVenture round $7.3M · 3 yr ago · 11-50 employees
VitalStream® is an FDA-approved and clinically-validated wireless, ICU-grade noninvasive hemodynamic and blood pressure monitor. Schedule a…

Financials

Total raised
$9.3M
Latest round
Angel
Funding rounds
2
Funding rounds
Round Announced Amount
Angel 2024 $6.6M Details
Grant 2020 $2.7M Details

News

News news.qq.com 2 years ago
Novostia获得约661万美元天使轮融资_腾讯新闻
Novostia是瑞士一家心血管设备开发商该公司致力于改善全球数百万患有主动脉瓣和二尖瓣病患者的生活质量同时降低整体医疗成本近日Novostia宣布成功完成560万瑞士法郎约661万美元融资...
Read more
Report
Press release businesswire 2 years ago
Novostia Announces New CEO and Secures Additional CHF 5.6 million in Funding
Novostia, a pioneering medical technology company, specializing in the development of a disruptive heart valve prosthesis, at clinical stage, today announces...
Read more
Report
News FinanzNachrichten.de 6 years ago
Novostia erhält EU-Zuschuss von 2,5 Mio. EUR zur Unterstützung seiner Herzklappentechnologie
Wie Novostia heute mitteilte, hat das Unternehmen im Rahmen von Horizon 2020 EIC Accelerator, dem europäischen Förderprogramm für kleine und mittlere Unternehmen (KMU), einen Zuschuss der Europäischen
Read more
Report